Intrinsiqq
MiNK Therapeutics, Inc. logo

MiNK Therapeutics, Inc. Insider Trading

INKT

Compare
Last 12 months

Insiders sold 120K and bought nothing on the open market.

None of the selling was scheduled in advance under a 10b5-1 plan. The last open-market buy by an executive or director was in May 2023.

Net open-market
−120K
0 buys · 4 sales
Under a 10b5-1 plan
0%
of the value sold
Insiders who bought / sold
0 / 2
executives and directors
Last open-market buy
May 2023
May 2, 2023

Get an email when INKT's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

  • Oct 12No plan
    Jennifer Buell
    Chief Executive Officer · sold 6,938 at $10.56
    73K
    8.6% of stake
  • Jun 4No plan
    Barbara Ryan
    Director · sold 1,500 at avg $12.76
    19K
    6.4% of stake
  • Mar 9 – 10No plan
    Barbara Ryan
    Director · sold 1,500 at avg $14.70
    22K
    6.8% of stake
  • Feb 27 – Mar 2No plan
    Barbara Ryan
    Director · sold 500 at avg $10.85
    5K
    2.2% of stake
How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch INKT, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Biological Products, (No Diagnostic Substances) · Pick stocks to compare with INKT

CompareIntrinsic value
MGTXMeiraGTx Holdings plc
$7.98-1.97%60
TSHATaysha Gene Therapies Inc.
$3.72-1.33%40
TWSTTwist Bioscience Corporation
$103.32-7.44%40
TCRXTScan Therapeutics Inc.
$0.15+2.03%0
PTHSPelthos Therapeutics Inc.
$6.38-8.73%0
IPSCCentury Therapeutics, Inc.
$1.17-11.74%40
VXRTVaxart Inc.
$0.33-8.33%84
VYGRVoyager Therapeutics Inc.
$1.53-4.97%10

Spot a number that looks wrong? Check it in INKT's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing INKT

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.